| 原料品名 | Eptifibatide |
|---|---|
| 原料中文名称 | 依替巴肽 |
| 中文别名 | 埃替非巴肽>99%;依菲巴特;MPA-HAR-GLY-ASP-TRP-PRO-CYS-NH2(DISULFIDE BRIDGE,MPA1-CYS6);依替巴肽;醋酸依菲巴特;伊菲巴特;依菲巴肽;依非巴特,埃替非巴肽,安普利肽 |
| 化学名称 | 2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid |
| 分子式 | C35H49N11O9S2 |
| 分子量 | 831.96 |
| CAS号 | 188627-80-7 |
| EINECS编号 | 暂无权限 |
| 结构式图片 | 暂无权限 |
| 美国DMF登记 | 暂无权限 |
供应商信息
| 企业名称 | Teva Pharmaceutical Industries Ltd |
|---|---|
| 企业类型 | 生产商 |
| 国家/地区 | 以色列 |
| 公司官网 | 暂无权限 |
| 公司简介 | We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,500 products is among the largest of any pharmaceutical company in the world. Nearly 200 million people in 60 countries benefit from one of Teva's quality medicines every day. We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterizes how we do business and approach medicine. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息（https://s.yaozh.com/Purchase/release），或联系药智通客服17318480790（微信同号） |
扩展信息
